Relationship between homocysteine and thrombotic disease

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Thrombosis Research

Background:

• Hyperhomocysteinemia results from disrupted sulfur amino acid metabolism due to vitamin deficiencies or genetic defects.
• Mild hyperhomocysteinemia is epidemiologically linked to increased risks of arteriosclerotic disease and stroke.

Purpose of the Study:

• To investigate the association between hyperhomocysteinemia and thrombosis.
• To explore the synergistic effects of hyperhomocysteinemia and activated protein C resistance on thrombotic disease.
• To understand the underlying mechanisms of vascular disease associated with elevated homocysteine using animal models.

Main Methods:

• Meta-analysis of 10 studies comparing 1200 patients with hyperhomocysteinemia to 1200 controls.
• Inclusion of methionine loading tests to enhance association detection.
• Utilizing animal models to study the effects of mild hyperhomocysteinemia on vascular and coagulation systems.

Main Results:

• Eight of ten studies showed a positive association between hyperhomocysteinemia and thrombosis, with odds ratios from 2 to 13.
• Methionine loading tests strengthened the observed association.
• Evidence suggests a synergistic effect between hyperhomocysteinemia and activated protein C resistance on thrombotic disease onset.

Conclusions:

• Mild hyperhomocysteinemia is a significant risk factor for thrombosis.
• Elevated homocysteine levels likely impact vascular disease through multifactorial mechanisms affecting vascular structure and coagulation.
• Further research using animal models is crucial for elucidating these complex mechanisms.